Never miss a Delaware County story!
Radnor startup Palvella Therapeutics is tackling rare conditions that currently have no approved treatment, writes John George for the Philadelphia Business Journal.
The company was…
Radnor’s Opsidio, which is working on developing monoclonal antibodies for treatment of fibrotic diseases, has raised $800,000 through a debt financing deal, writes…
Before we send you to this site, please subscribe to our daily newsletter.